Logo image of ASAN

ASANA INC - CL A (ASAN) Stock Fundamental Analysis

NYSE:ASAN - New York Stock Exchange, Inc. - US04342Y1047 - Common Stock - Currency: USD

14.01  -0.13 (-0.92%)

Fundamental Rating

3

ASAN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. ASAN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ASAN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ASAN had negative earnings in the past year.
In the past year ASAN had a positive cash flow from operations.
In the past 5 years ASAN always reported negative net income.
ASAN had negative operating cash flow in 4 of the past 5 years.
ASAN Yearly Net Income VS EBIT VS OCF VS FCFASAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -26.43%, ASAN is doing worse than 70.07% of the companies in the same industry.
ASAN has a worse Return On Equity (-98.11%) than 75.70% of its industry peers.
Industry RankSector Rank
ROA -26.43%
ROE -98.11%
ROIC N/A
ROA(3y)-32.7%
ROA(5y)-33.56%
ROE(3y)-101.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASAN Yearly ROA, ROE, ROICASAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 500 1K 1.5K

1.3 Margins

The Gross Margin of ASAN (89.36%) is better than 97.18% of its industry peers.
In the last couple of years the Gross Margin of ASAN has remained more or less at the same level.
ASAN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y0.75%
ASAN Yearly Profit, Operating, Gross MarginsASAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

ASAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ASAN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ASAN has more shares outstanding
ASAN has a better debt/assets ratio than last year.
ASAN Yearly Shares OutstandingASAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ASAN Yearly Total Debt VS Total AssetsASAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

ASAN has an Altman-Z score of 0.29. This is a bad value and indicates that ASAN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.29, ASAN is doing worse than 68.66% of the companies in the same industry.
ASAN has a debt to FCF ratio of 3.49. This is a good value and a sign of high solvency as ASAN would need 3.49 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.49, ASAN is in the better half of the industry, outperforming 63.73% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that ASAN is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.16, ASAN perfoms like the industry average, outperforming 49.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 3.49
Altman-Z 0.29
ROIC/WACCN/A
WACC11.29%
ASAN Yearly LT Debt VS Equity VS FCFASAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.47 indicates that ASAN should not have too much problems paying its short term obligations.
ASAN has a Current ratio (1.47) which is comparable to the rest of the industry.
A Quick Ratio of 1.47 indicates that ASAN should not have too much problems paying its short term obligations.
The Quick ratio of ASAN (1.47) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.47
ASAN Yearly Current Assets VS Current LiabilitesASAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

ASAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 88.89%, which is quite impressive.
ASAN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.83%.
ASAN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.39% yearly.
EPS 1Y (TTM)88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
Revenue 1Y (TTM)9.83%
Revenue growth 3Y24.14%
Revenue growth 5Y38.39%
Sales Q2Q%8.59%

3.2 Future

The Earnings Per Share is expected to grow by 43.10% on average over the next years. This is a very strong growth
Based on estimates for the next years, ASAN will show a quite strong growth in Revenue. The Revenue will grow by 11.60% on average per year.
EPS Next Y248.79%
EPS Next 2Y114.99%
EPS Next 3Y79.02%
EPS Next 5Y43.1%
Revenue Next Year8.07%
Revenue Next 2Y8.86%
Revenue Next 3Y10.01%
Revenue Next 5Y11.6%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ASAN Yearly Revenue VS EstimatesASAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
ASAN Yearly EPS VS EstimatesASAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASAN. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 41.10 indicates a quite expensive valuation of ASAN.
The rest of the industry has a similar Price/Forward Earnings ratio as ASAN.
The average S&P500 Price/Forward Earnings ratio is at 22.40. ASAN is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 41.1
ASAN Price Earnings VS Forward Price EarningsASAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

ASAN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 302.24
EV/EBITDA N/A
ASAN Per share dataASAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

ASAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ASAN's earnings are expected to grow with 79.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.99%
EPS Next 3Y79.02%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASAN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASANA INC - CL A

NYSE:ASAN (6/12/2025, 11:06:42 AM)

14.01

-0.13 (-0.92%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-03 2025-06-03/amc
Earnings (Next)09-01 2025-09-01/amc
Inst Owners50.87%
Inst Owner Change-2.11%
Ins Owners38.83%
Ins Owner Change3.68%
Market Cap3.30B
Analysts68.33
Price Target16.25 (15.99%)
Short Float %10.84%
Short Ratio4.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)127.19%
Min EPS beat(2)100%
Max EPS beat(2)154.38%
EPS beat(4)4
Avg EPS beat(4)91.3%
Min EPS beat(4)39.8%
Max EPS beat(4)154.38%
EPS beat(8)8
Avg EPS beat(8)72.8%
EPS beat(12)12
Avg EPS beat(12)59.39%
EPS beat(16)16
Avg EPS beat(16)48.22%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)-1.03%
Revenue beat(4)0
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-1.84%
Max Revenue beat(4)-0.22%
Revenue beat(8)3
Avg Revenue beat(8)-0.45%
Revenue beat(12)5
Avg Revenue beat(12)0.05%
Revenue beat(16)9
Avg Revenue beat(16)1.19%
PT rev (1m)0%
PT rev (3m)-22.08%
EPS NQ rev (1m)16.14%
EPS NQ rev (3m)1200.92%
EPS NY rev (1m)-1.94%
EPS NY rev (3m)2056.97%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-2.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 41.1
P/S 4.47
P/FCF 302.24
P/OCF 139.84
P/B 13.96
P/tB 13.96
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)0.34
Fwd EY2.43%
FCF(TTM)0.05
FCFY0.33%
OCF(TTM)0.1
OCFY0.72%
SpS3.14
BVpS1
TBVpS1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.43%
ROE -98.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.36%
FCFM 1.48%
ROA(3y)-32.7%
ROA(5y)-33.56%
ROE(3y)-101.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y0.75%
F-Score5
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 3.49
Debt/EBITDA N/A
Cap/Depr 68.54%
Cap/Sales 1.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.47
Altman-Z 0.29
F-Score5
WACC11.29%
ROIC/WACCN/A
Cap/Depr(3y)72.76%
Cap/Depr(5y)478.8%
Cap/Sales(3y)1.67%
Cap/Sales(5y)8.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
EPS Next Y248.79%
EPS Next 2Y114.99%
EPS Next 3Y79.02%
EPS Next 5Y43.1%
Revenue 1Y (TTM)9.83%
Revenue growth 3Y24.14%
Revenue growth 5Y38.39%
Sales Q2Q%8.59%
Revenue Next Year8.07%
Revenue Next 2Y8.86%
Revenue Next 3Y10.01%
Revenue Next 5Y11.6%
EBIT growth 1Y9.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year226.6%
EBIT Next 3Y67.88%
EBIT Next 5Y41.95%
FCF growth 1Y107.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.67%
OCF growth 3YN/A
OCF growth 5YN/A